Article Type
Changed
Display Headline
Genetic Test for Psoriatic Arthritis

PsoriasisDX, the first commercially available genetic test for psoriatic arthritis, can help detect the condition before symptoms develop, allowing for less joint damage through early treatment. This is important because medications for psoriatic arthritis can prevent joint destruction but not reverse damage once it occurs. Using the PsoriasisDX Genetic Test kit, a cheek swab sample is sent to the laboratory for analysis. The gene variant MICA-A9 is found in approximately 60% of those who develop PsA; if the variant is not present, the patient has an approximately 70% chance of not getting the condition. The kit is $399 and available through qualified physicians.

PsoriasisDX

www.psoriasisdx.com

Author and Disclosure Information

Publications
Topics
Author and Disclosure Information

Author and Disclosure Information

PsoriasisDX, the first commercially available genetic test for psoriatic arthritis, can help detect the condition before symptoms develop, allowing for less joint damage through early treatment. This is important because medications for psoriatic arthritis can prevent joint destruction but not reverse damage once it occurs. Using the PsoriasisDX Genetic Test kit, a cheek swab sample is sent to the laboratory for analysis. The gene variant MICA-A9 is found in approximately 60% of those who develop PsA; if the variant is not present, the patient has an approximately 70% chance of not getting the condition. The kit is $399 and available through qualified physicians.

PsoriasisDX

www.psoriasisdx.com

PsoriasisDX, the first commercially available genetic test for psoriatic arthritis, can help detect the condition before symptoms develop, allowing for less joint damage through early treatment. This is important because medications for psoriatic arthritis can prevent joint destruction but not reverse damage once it occurs. Using the PsoriasisDX Genetic Test kit, a cheek swab sample is sent to the laboratory for analysis. The gene variant MICA-A9 is found in approximately 60% of those who develop PsA; if the variant is not present, the patient has an approximately 70% chance of not getting the condition. The kit is $399 and available through qualified physicians.

PsoriasisDX

www.psoriasisdx.com

Publications
Publications
Topics
Article Type
Display Headline
Genetic Test for Psoriatic Arthritis
Display Headline
Genetic Test for Psoriatic Arthritis
Article Source

PURLs Copyright

Inside the Article